Life-Threatening Endocrinological Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy
Malignant neoplasms are currently one of the leading causes of morbidity and mortality worldwide, posing a major public health challenge. However, recent advances in research in cancer biology and immunity have led to the development of immunotherapy, which is now used on an everyday basis in cancer...
Main Authors: | Aleksandra Basek, Grzegorz K. Jakubiak, Grzegorz Cieślar, Agata Stanek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/24/5786 |
Similar Items
-
Pancreatic adverse events in patients treated with immune checkpoint inhibitors
by: Caroline Hana, et al.
Published: (2023-03-01) -
Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study
by: E. V. Poddubskaya, et al.
Published: (2019-12-01) -
Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review
by: Won Sang Yoo, et al.
Published: (2023-12-01) -
Immune-related endocrine disorders in novel immune checkpoint inhibition therapy
by: Le Min
Published: (2016-12-01) -
Autoantibodies involved in primary and secondary adrenal insufficiency following treatment with immune checkpoint inhibitors
by: N.C. Helderman, et al.
Published: (2023-03-01)